Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ezio Zanon

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Haematologica|July 4, 2007
Clinical use of Haemate P in inherited von Willebrand's disease: a cohort study on 100 Italian patientsAugusto B Federici, Giancarlo Castaman, Massimo Franchini, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 12, 2019
Immune tolerance induction with moroctocog-alpha (Refacto/Refacto AF) in a population of Italian haemophilia A patients with high-titre inhibitors: Data from REF.IT RegistryEzio Zanon, Samantha Pasca, Berardino Pollio, et al.
European Journal of Haematology|May 9, 2022
Use of the von Willebrand factor concentrate with low factor VIII content to manage patients with inherited von Willebrand disease requiring surgical or secondary long-term prophylaxis: An expert opinion paper from an Italian panelGiancarlo Castaman, Alessandra Borchiellini, Antonio Coppola, et al.
Research and Practice in Thrombosis and Haemostasis|April 17, 2025
Joint health status in people with moderate hemophilia A: a cross-sectional multicenter studyIlenia Lorenza Calcaterra, Federico Picasso, Federica Valeri, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 20, 2023
Health Related Quality of Life and Psychopathological Symptoms in People with Hemophilia, Bloodborne Co-Infections and Comorbidities: An Italian Multicenter Observational StudyMario Schiavoni, Carlo Pruneti, Sara Guidotti, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 21, 2024
Real-World Efficacy and Safety of Plasma-Derived Von Willebrand Factor-Containing Factor VIII Concentrates in Patients With Von Willebrand Disease in ItalyAugusto B Federici, Rita Carlotta Santoro, Cristina Santoro, et al.
Journal of Thrombosis and Thrombolysis|November 14, 2021
Italian experience with rVIII-single chain: a survey of patients with haemophilia A and their physiciansAlessandra Borchiellini, Giancarlo Castaman, Giulio Feola, et al.
Blood Transfusion = Trasfusione Del Sangue|January 10, 2018
Current challenges in the diagnosis and management of patients with inherited von Willebrand's disease in Italy: an Expert Meeting Report on the diagnosis and surgical and secondary long-term prophylaxisPiercarla Schinco, Giancarlo Castaman, Antonio Coppola, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 2, 2021
Predictors of inhibitor eradication by primary immune tolerance induction in severe haemophilia A with high responding inhibitorsGiovanni Di Minno, Antonio Coppola, Maurizio Margaglione, et al.
Blood Advances|September 3, 2024
Liver-related aspects of valoctocogene roxaparvovec gene therapy for hemophilia A: expert guidance for clinical practiceVincenzo La Mura, Vincenzo Cardinale, Raimondo De Cristofaro, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Haematologica|July 4, 2007
Clinical use of Haemate P in inherited von Willebrand's disease: a cohort study on 100 Italian patientsAugusto B Federici, Giancarlo Castaman, Massimo Franchini, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 12, 2019
Immune tolerance induction with moroctocog-alpha (Refacto/Refacto AF) in a population of Italian haemophilia A patients with high-titre inhibitors: Data from REF.IT RegistryEzio Zanon, Samantha Pasca, Berardino Pollio, et al.
European Journal of Haematology|May 9, 2022
Use of the von Willebrand factor concentrate with low factor VIII content to manage patients with inherited von Willebrand disease requiring surgical or secondary long-term prophylaxis: An expert opinion paper from an Italian panelGiancarlo Castaman, Alessandra Borchiellini, Antonio Coppola, et al.
Research and Practice in Thrombosis and Haemostasis|April 17, 2025
Joint health status in people with moderate hemophilia A: a cross-sectional multicenter studyIlenia Lorenza Calcaterra, Federico Picasso, Federica Valeri, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 20, 2023
Health Related Quality of Life and Psychopathological Symptoms in People with Hemophilia, Bloodborne Co-Infections and Comorbidities: An Italian Multicenter Observational StudyMario Schiavoni, Carlo Pruneti, Sara Guidotti, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 21, 2024
Real-World Efficacy and Safety of Plasma-Derived Von Willebrand Factor-Containing Factor VIII Concentrates in Patients With Von Willebrand Disease in ItalyAugusto B Federici, Rita Carlotta Santoro, Cristina Santoro, et al.
Journal of Thrombosis and Thrombolysis|November 14, 2021
Italian experience with rVIII-single chain: a survey of patients with haemophilia A and their physiciansAlessandra Borchiellini, Giancarlo Castaman, Giulio Feola, et al.
Blood Transfusion = Trasfusione Del Sangue|January 10, 2018
Current challenges in the diagnosis and management of patients with inherited von Willebrand's disease in Italy: an Expert Meeting Report on the diagnosis and surgical and secondary long-term prophylaxisPiercarla Schinco, Giancarlo Castaman, Antonio Coppola, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 2, 2021
Predictors of inhibitor eradication by primary immune tolerance induction in severe haemophilia A with high responding inhibitorsGiovanni Di Minno, Antonio Coppola, Maurizio Margaglione, et al.
Blood Advances|September 3, 2024
Liver-related aspects of valoctocogene roxaparvovec gene therapy for hemophilia A: expert guidance for clinical practiceVincenzo La Mura, Vincenzo Cardinale, Raimondo De Cristofaro, et al.
Pageof 8